Gsa Capital Partners LLP Aurinia Pharmaceuticals Inc. Transaction History
Gsa Capital Partners LLP
- $1.43 Billion
- Q2 2025
A detailed history of Gsa Capital Partners LLP transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 279,418 shares of AUPH stock, worth $3.16 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
279,418
Previous 88,911
214.27%
Holding current value
$3.16 Million
Previous $715,000
231.05%
% of portfolio
0.17%
Previous 0.06%
Shares
10 transactions
Others Institutions Holding AUPH
# of Institutions
240Shares Held
65MCall Options Held
1.14MPut Options Held
825K-
Tang Capital Management LLC San Diego, CA10MShares$114 Million5.24% of portfolio
-
Black Rock Inc. New York, NY9.27MShares$105 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5MShares$56.6 Million0.61% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$44.9 Million3.03% of portfolio
-
State Street Corp Boston, MA2.8MShares$31.6 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.61B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...